Tyra Biosciences (TYRA) Shares Issued (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Shares Issued came in at $6.0 million in Q1 2026, down 41.23% YoY from $10.2 million in Q1 2025, and down 56.13% on a QoQ basis from $13.6 million in Q4 2025.
Tyra Biosciences (TYRA) Shares Issued (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Shares Issued data on file, last reported at $6.0 million in Q1 2026.
- Quarterly Shares Issued fell 41.23% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 41.23% YoY) and the FY2025 annual result came in at $13.6 million, up 30.16% from the prior year.
- Shares Issued eased to $6.0 million in Q1 2026, from $13.6 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $13.6 million in Q4 2025 to a low of $891348.0 in Q1 2022.
- A 5-year average of $6.6 million and a median of $6.0 million in 2026 frame the typical range for Shares Issued.
- The widest YoY moves for Shares Issued: up 587.28% in 2023, down 54.24% in 2023.
- Tracing TYRA's Shares Issued over 5 years: stood at $5.9 million in 2022, then jumped by 40.5% to $8.3 million in 2023, then climbed by 26.41% to $10.5 million in 2024, then jumped by 30.16% to $13.6 million in 2025, then slumped by 56.13% to $6.0 million in 2026.
- The last three Shares Issued figures came in at $6.0 million (Q1 2026), $13.6 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41 Mn |
| Jun 30, 2026 | 14.41 Mn |
| Mar 31, 2026 | 5.97 Mn |
| Mar 31, 2026 | 5.97 Mn |
| Dec 31, 2025 | 13.62 Mn |
| Dec 31, 2025 | 13.62 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.46 Mn |
| Mar 31, 2025 | 10.17 Mn |
| Mar 31, 2025 | 10.17 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Sep 30, 2024 | 10.75 Mn |
| Sep 30, 2024 | 10.75 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Mar 31, 2024 | 3.66 Mn |